These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Ximelagatran data fail to impress FDA. Thompson CA Am J Health Syst Pharm; 2004 Dec; 61(23):2472, 2474-5, 2480. PubMed ID: 15595219 [No Abstract] [Full Text] [Related]
4. [Ximelagatran: hopes and controversies]. Bressollette L J Mal Vasc; 2005 Jul; 30(3):142-3. PubMed ID: 16142177 [No Abstract] [Full Text] [Related]
5. A better way to prevent blood clots? A drug derived from cobra venom offers an alternative to warfarin, although liver problems temper its benefits. Harv Heart Lett; 2005 May; 15(9):3. PubMed ID: 15898148 [No Abstract] [Full Text] [Related]
7. [Prevention and treatment of deep vein thrombosis with ximelagatran]. Caspary L; Bauersachs R; Brehme S; Creutzig A; Harenberg J; Hoffmann U; Landgraf H; Schellong S Dtsch Med Wochenschr; 2004 Jul; 129(30):1635-40. PubMed ID: 15257504 [No Abstract] [Full Text] [Related]
8. A new oral anticoagulant: the 50-year challenge. Gustafsson D; Bylund R; Antonsson T; Nilsson I; Nyström JE; Eriksson U; Bredberg U; Teger-Nilsson AC Nat Rev Drug Discov; 2004 Aug; 3(8):649-59. PubMed ID: 15286732 [No Abstract] [Full Text] [Related]
9. A preliminary assessment of the critical differences between novel oral anticoagulants currently in development. McBride BF J Clin Pharmacol; 2005 Sep; 45(9):1004-17. PubMed ID: 16100294 [TBL] [Abstract][Full Text] [Related]
10. Ximelagatran: a new type of oral anticoagulant. Kwok L; Molckovsky D; Boucher M Int J Technol Assess Health Care; 2005; 21(4):480-6. PubMed ID: 16262971 [TBL] [Abstract][Full Text] [Related]
11. [Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?]. Selçuk H; Selçuk MT; Maden O Anadolu Kardiyol Derg; 2007 Mar; 7(1):54-8. PubMed ID: 17347079 [TBL] [Abstract][Full Text] [Related]